Neuroimaging revolutionizes therapeutic approaches to chronic pain

An understanding of how the brain changes in chronic pain or responds to pharmacological or other therapeutic interventions has been significantly changed as a result of developments in neuroimaging of the CNS. These developments have occurred in 3 domains : (1) Anatomical Imaging which has demonstrated changes in brain volume in chronic pain; (2) Functional Imaging (fMRI) that has demonstrated an altered state in the brain in chronic pain conditions including back pain, neuropathic pain, and complex regional pain syndromes. In addition the response of the brain to drugs has provided new insights into how these may modify normal and abnormal circuits (phMRI or pharmacological MRI); (3) Chemical Imaging (Magnetic Resonance Spectroscopy or MRS) has helped our understanding of measures of chemical changes in chronic pain. Taken together these three domains have already changed the way in which we think of pain – it should now be considered an altered brain state in which there may be altered functional connections or systems and a state that has components of degenerative aspects of the CNS.

[1]  S. Rombouts,et al.  Consistent resting-state networks across healthy subjects , 2006, Proceedings of the National Academy of Sciences.

[2]  Irene Tracey,et al.  An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients , 2006, NeuroImage.

[3]  J. W. Brooks,et al.  Cannabinoids and pain , 2003 .

[4]  A. Apkarian,et al.  Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density , 2004, The Journal of Neuroscience.

[5]  P. Gerner,et al.  Amitriptyline versus Bupivacaine in Rat Sciatic Nerve Blockade , 2001, Anesthesiology.

[6]  G. Cabral,et al.  Cannabinoid receptors in microglia of the central nervous system: immune functional relevance , 2005, Journal of leukocyte biology.

[7]  Rex E. Jung,et al.  A novel technique to study the brain's response to pain: Proton magnetic resonance spectroscopy , 2005, NeuroImage.

[8]  David Borsook,et al.  Capsaicin-induced thermal hyperalgesia and sensitization in the human trigeminal nociceptive pathway: An fMRI study , 2007, NeuroImage.

[9]  R. Baron,et al.  Complex regional pain syndrome is a disease of the central nervous system , 2002, Clinical Autonomic Research.

[10]  M. Fava.  The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. , 2003, The Journal of clinical psychiatry.

[11]  W Vennart,et al.  Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Chattarji,et al.  Chronic Stress Induces Contrasting Patterns of Dendritic Remodeling in Hippocampal and Amygdaloid Neurons , 2002, The Journal of Neuroscience.

[13]  G. Jackson,et al.  Functional connectivity networks are disrupted in left temporal lobe epilepsy , 2006, Annals of neurology.

[14]  David Borsook,et al.  A role for fMRI in optimizing CNS drug development , 2006, Nature Reviews Drug Discovery.

[15]  The effect of sodium valproate on proton MRS visible neurochemical concentrations , 2007, Epilepsy Research.

[16]  C. Newton,et al.  The cannabinoid system and cytokine network. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  S. Bluml,et al.  Magnetic resonance spectroscopy of the human brain , 2001, The Anatomical record.

[18]  N. Schuff,et al.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. , 2006, Brain : a journal of neurology.

[19]  Igor D. Grachev,et al.  Decreased Levels of N-Acetylaspartate in Dorsolateral Prefrontal Cortex in a Case of Intractable Severe Sympathetically Mediated Chronic Pain (Complex Regional Pain Syndrome, Type I) , 2002, Brain and Cognition.

[20]  C. Newton,et al.  The cannabinoid system and immune modulation , 2003, Journal of leukocyte biology.

[21]  David A Seminowicz,et al.  Accelerated Brain Gray Matter Loss in Fibromyalgia Patients: Premature Aging of the Brain? , 2007, The Journal of Neuroscience.

[22]  Bridget A. Martell,et al.  Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction , 2007, Annals of Internal Medicine.

[23]  M. L. Sotgiu,et al.  AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain , 2006, British journal of pharmacology.

[24]  N. B. Finnerupa,et al.  Algorithm for neuropathic pain treatment: An evidence based proposal , 2005 .

[25]  Y. Nagumo,et al.  Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice , 2007, Neuroscience Letters.

[26]  Y. Sarne,et al.  Cannabinoids: between neuroprotection and neurotoxicity. , 2005, Current drug targets. CNS and neurological disorders.

[27]  J. Mao.  Opioid-induced abnormal pain sensitivity , 2006, Current pain and headache reports.

[28]  T. Nurmikko,et al.  EFNS guidelines on pharmacological treatment of neuropathic pain , 2006, European journal of neurology.

[29]  Uwe Himmelreich,et al.  Magnetic Resonance Spectroscopy Detects Biochemical Changes in the Brain Associated with Chronic Low Back Pain: A Preliminary Report , 2006, Anesthesia and analgesia.

[30]  E. Gardner.  Endocannabinoid signaling system and brain reward: Emphasis on dopamine , 2005, Pharmacology Biochemistry and Behavior.

[31]  Cristina Granziera,et al.  Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine , 2007, Neuroreport.

[32]  David Borsook,et al.  Trigeminal Neuropathic Pain Alters Responses in CNS Circuits to Mechanical (Brush) and Thermal (Cold and Heat) Stimuli , 2006, The Journal of Neuroscience.

[33]  W Wolf,et al.  19F-MRS studies of fluorinated drugs in humans. , 2000, Advanced drug delivery reviews.

[34]  David Borsook,et al.  Antineuropathic effects of the antibiotic derivative spicamycin KRN5500. , 2004, Pain medicine.

[35]  H. J. McQuay,et al.  Algorithm for neuropathic pain treatment: An evidence based proposal , 2005, Pain.

[36]  M. Backonja,et al.  Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. , 2000, Drugs.

[37]  Gian Domenico Iannetti,et al.  Chapter 6 Brainstem functional imaging in humans , 2006 .

[38]  M Wilke,et al.  1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1 , 2005, Neurology.

[39]  I. Galve-Roperh,et al.  The Endocannabinoid System and Neurogenesis in Health and Disease , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[40]  R. Yezierski,et al.  Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury. , 2002, AJNR. American journal of neuroradiology.

[41]  Marnie E. Shaw,et al.  Reward‐aversion circuitry in analgesia and pain: Implications for psychiatric disorders , 2007, European journal of pain.

[42]  M. V. Centeno,et al.  d-Cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry , 2007, Pain.

[43]  D. Chialvo,et al.  Chronic Pain and the Emotional Brain: Specific Brain Activity Associated with Spontaneous Fluctuations of Intensity of Chronic Back Pain , 2006, The Journal of Neuroscience.

[44]  E. Villegas,et al.  Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. , 2007, Natural product reports.

[45]  E. Bruera,et al.  Dose ratio between morphine and methadone in patients with cancer pain , 1998, Cancer.

[46]  M. Mortari,et al.  Neurotoxins from invertebrates as anticonvulsants: from basic research to therapeutic application. , 2007, Pharmacology & therapeutics.

[47]  C. Newton,et al.  The Cannabinoid System and Cytokine Network (44546) , 2000 .

[48]  G. Fava.  Can long-term treatment with antidepressant drugs worsen the course of depression? , 2003, The Journal of clinical psychiatry.

[49]  John C Gore,et al.  Assessing functional connectivity in the human brain by fMRI. , 2007, Magnetic resonance imaging.

[50]  Gian Domenico Iannetti,et al.  Brainstem functional imaging in humans. , 2006, Supplements to Clinical neurophysiology.

[51]  G. Cavaletti,et al.  Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis , 2007, Neuroscience.

[52]  B. Neundörfer,et al.  Cortical reorganization during recovery from complex regional pain syndrome , 2004, Neurology.

[53]  L. Chang,et al.  Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. , 2006, Brain : a journal of neurology.

[54]  J. Deleo,et al.  Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. , 2001, The Journal of pharmacology and experimental therapeutics.

[55]  A. Vania Apkarian,et al.  Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study , 2000, Pain.